Delayed Graft Function Completed Phase 2 / 3 Trials for Eculizumab (DB01257)

Also known as: Graft Function, Delayed

IndicationStatusPhase
DBCOND0004880 (Delayed Graft Function)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02145182Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)Prevention